New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 7, 2012
12:16 EDTJNPR, AAPL, ACI, HCA, PLXS, VHC, ANR, THC, STEC, AMRS, BTU, CYHOn The Fly: Midday Wrap
Stocks on Wall Street were down over 2.25% at midday following the re-election of Barack Obama as President. Stocks began the day sharply lower and saw hardly a hint of buying during the session's early hours. The market selling picked up speed after the first hour of trading and the averages sat near their lows of the day at lunch hour. While investors repositioned after the U.S. election, news from Europe did nothing to help matters. ECB President Mario Draghi said he was anticipating weakness in the European economy for the foreseeable future and that Germany was now being impacted... ECONOMIC EVENTS: In the U.S., President Obama was re-elected and Congress remains split, with Republicans keeping control of the House of Representatives and Democrats maintaining their grip on the Senate. While no excuses remain for not addressing the fiscal cliff, the climate of partisanship may make it difficult to strike a compromise before January 1, if at all. In Europe, the European Commission lowered its 2013 growth forecast for region's economy to 0.1% from a prior call for 1% growth. Also, German industrial production fell 1.8% in September from the prior month, which was worse than forecast. Draghi summed up both data points in a speech, putting a fine point on the European troubles that magnified the dour tone of the U.S. market... COMPANY NEWS: Hospital stocks were among the few gainers following Obama's win, with Tenet Healthcare (THC) up about 7.7%, HCA Holdings (HCA) up 7.7% and Community Health Systems (CYH) up 6.4%. Conversely, coal stocks, which had been strong since Romney's pro-coal statements during the debates, fell sharply, with Alpha Natural Resources (ANR) down 10.6%, Arch Coal (ACI) down 12.7% and Peabody Energy (BTU) down 8.6%... MAJOR MOVERS: Among the notable gainers were VirnetX (VHC), up almost 18% after a jury awarded the company over $368M in a patent verdict against Apple (AAPL), and Amyris (AMRS), up 20% after its quarterly revenues were better than expected and its losses were not as bad as forecast. Among the noteworthy losers was Plexus (PLXS), which fell 28% after Juniper (JNPR) dropped the company as a supplier. Also lower were shares of STEC (STEC), which was downgraded at Craig-Hallum and Lazard Capital and slid over 23% after its disappointing guidance for its upcoming quarter... INDICES: Near noon, the Dow was down 306.25, or 2.31%, to 12,939.43; the Nasdaq was down 72.10, or 2.39%, to 2,939.83; and the S&P 500 was down 33.22, or 2.33%, to 1,395.17.
News For THC;HCA;CYH;ANR;ACI;BTU;VHC;AAPL;AMRS;PLXS;JNPR;STEC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>
January 27, 2016
09:37 EDTAAPLApple drops after earnings and outlook
Shares are down over 4% to $95.82 following earnings and outlook announced after the close yesterday. At current price support is at the 52-week low at $92. Resistance is at $96.87.
09:32 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL FB AMZN AAL BAC PCLN NFLX MRK GOOG
09:12 EDTAAPLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Biogen (BIIB), up 5.6%... Hawaiian Holdings (HA), up 6.7%... Capital One (COF), up 1.5%. ALSO HIGHER: Capnia (CAPN), up 34.1% after entering into an exclusive distribution agreement with Bemes... Fate Therapeutics (FATE), up 18.6% after announcing that the FDA has cleared the company's investigational new drug application for ProTmune... Raptor Pharmaceutical (RPTP), up 12.1% after being upgraded to Buy from Neutral at Citi... Aquinox (AQXP), up 5.6% after Baker Bros. buys 140,786 shares in the company... Sunedison (SUNE), up 7.4% after SunEdison and Greenlight Capital announced that they have mutually agreed to corporate governance initiatives... Citizens Financial Group (CFG), up 3% after it will be added to the S&P 500... Terex (TEX), up 5.2% after being upgraded to Neutral from Underweight at JPMorgan. DOWN AFTER EARNINGS: Tupperware Brands (TUP), down 11.4%... VMware (VMW), down 6.5%... Textron (TXT), down 9.9%... Cliffs Natural (CLF), down 5.8%... Boeing (BA), down 6.2%... Fiat Chrysler (FCAU), down 3%... Apple (AAPL), down 3.4%. ALSO LOWER: Priceline (PCLN), down 2.9% after being downgraded to Neutral from Buy at Goldman... Bed Bath & Beyond (BBBY), down 4.2% after being downgraded at Citi and KeyBanc... Tripadvisor (TRIP), down 5.5% after being downgraded to Sell from Neutral at Goldman.
08:16 EDTAAPLApple set-up 'increasingly attractive,' says Bernstein
Subscribe for More Information
08:11 EDTAAPLApple guidance better than feared, says Morgan Stanley
Subscribe for More Information
08:02 EDTAAPLApple price target lowered to $120 from $140 at Stifel
Subscribe for More Information
07:57 EDTAAPLCiti recommends buying Skyworks on Apple weakness
Subscribe for More Information
07:49 EDTAAPLApple revenue view already factored in Skyworks, Qorvo shares, says Stephens
Subscribe for More Information
07:45 EDTAAPLApple price target lowered to $130 from $145 at Citi
Subscribe for More Information
07:39 EDTAAPLApple price target lowered to $130 from $150 at FBR Capital
FBR Capital analyst Daniel Ives says Apple CEO Tim Cook "finally ripped the band-aid off" and lowered the company's outlook based on softer iPhone 6S demand and a choppy macro environment. Apple has a "few tough quarters ahead" pending the iPhone 7 buildup later this year, Ives tells investors in a post-earnings research note. He lowered his price target for the iPhone maker to $130 from $150 and keeps an Outperform rating on the name.
07:36 EDTAAPLApple price target lowered to $120 from $130 at UBS
Subscribe for More Information
07:33 EDTAAPLApple to remain range bound , says RBC Capital
Subscribe for More Information
07:23 EDTAAPLApple guidance more firm than expected, says Brean Capital
Subscribe for More Information
07:18 EDTAAPLApple outlook still positive, says Oppenheimer
After Apple's guidance indicated that iPhone sales would decline during the current quarter, Oppenheimer nonetheless believes that the company's "growth potential in China and other emerging markets has not been fully realized." The firm says that patient investors in the stock will be rewarded. It keeps a $120 price target and Outperform rating on the shares.
07:03 EDTAAPLDeutsche still sees limited catalysts for Apple shares
Deutsche Bank analyst Sherri Scribner says Apple's March quarter guidance implies a "significant decline" year-over-year in iPhone units, which likely drives a decline for FY16. The analyst remains concerned about the lack of growth in iPhone units this year, the slowdown in China sales and gross margin pressure following Apple's Q1 results. She sees limited catalysts for the shares in the near term and expects the stock to be range-bound. In a post-earnings research note titled "Is Apple season over?", Scribner keeps a Hold rating on the iPhone maker with a $105 price target.
06:59 EDTAAPLOptions expected to be active: AAPL FB AMZN BIIB GD HES TXT BA UTX X T
Subscribe for More Information
06:35 EDTAAPLiPhone 7 Plus may include dual camera system, 9to5Mac reports
Apple's iPhone 7 Plus will likely include a dual-camera system, 9to5Mac reports, citing Apple analyst KGI securities. By using two separate lenses, Apple can use the additional image data to create higher quality pictures, the report says. Reference Link
06:28 EDTAAPLApple reported strong Q1 but guided weak for Q2, says JPMorgan
Subscribe for More Information
06:20 EDTAAPLPiper's Munster says Apple remains top pick for 2016
Piper Jaffray analyst Gene Munster believes Apple's "insistence on broader macroeconomic headwinds" during its Q1 earnings conference call "may have spooked investors." He points out shares are trading down 3% despite iPhone guidance coming in above buy-side expectations. If macro headwinds remain an issue for Apple, the entire market would be impacted and the iPhone maker would be a relative winner, Munster tells investors in a post-earnings research note. He believes investors will view the safety of Apple's capital return program as a positive. Munster still predicts multiple expansion for Apple given the iPhone 7 and easier comps at the end of the year. The analyst lowered his price target for the stock to $172 from $179 but says Apple remains his top pick for 2016.
05:47 EDTAAPLTwitter close to hiring Natalie Kerris to run communications unit, Re/code says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use